Evaluation of Preclinical Toxicity andTherapeutic Efficacy of Kandhaga Rasayanam in Padarthamarai

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

this study is intended to find out the therapeutic efficacy of the siddha drug Kandhaga Rasayanam in Padarthamarai ( Ring worm infection )

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National institute of Siddha

Criteria

Inclusion Criteria:

• patients clinically diagnosed with tinea infection.

• direct microscopy skin scraping test positive.

Exclusion Criteria:

• pregnant or nursing women.

• use of other topical or oral antifungals, immunosuppressive drugs, anthelmintic drugs either currently or during 2 weeks preceeding initiation of drug trial.

• allergy or hyperensitivity to any component of the drug.

• clinical case of eczema, lichen planus, pityriasis versicolor, drug induced eruptions, urticaria, intertrigo, tinea ungium.

• diabetic patients.